Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma

NCT01434849 is registered in ClinicalTrials.gov with Alice K. Gong as lead sponsor.

NCT NCT01434849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01434849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma
Lead sponsor
Alice K. Gong
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2012
Completion date
April 30, 2016
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infantile hemangioma, very low birth weight infants